DaVita Inc. (DVA)

Market Cap	11.39B
Revenue (ttm)	12.82B
Net Income (ttm)	936.34M
Shares Out	80.00M
EPS (ttm)	10.73
PE Ratio	13.27
Forward PE	12.87
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,605,084
Open	144.38
Previous Close	145.92
Day's Range	141.00 - 144.76
52-Week Range	122.65 - 179.60
Beta	0.93
Analysts	Hold
Price Target	154.40 (+8.43%)
Earnings Date	Feb 13, 2025

About DVA

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Oct 31, 1995
• Employees: 76,000
• Stock Exchange: NYSE
• Ticker Symbol: DVA
• Website: https://www.davita.com

Financial Performance

In 2024, DaVita's revenue was $12.82 billion, an increase of 5.56% compared to the previous year's $12.14 billion. Earnings were $936.34 million, an increase of 35.40%.

Analyst Forecast

According to 5 analysts, the average rating for DVA stock is "Hold." The 12-month stock price forecast is $154.4, which is an increase of 8.43% from the latest price.

Price Target

$154.4

(8.43% upside)

Analyst Consensus: Hold